Beside the anti-CD147 antibody strategy, a small molecule (AC-73) inhibitor of CD147 dimerization has been shown to decrease MMP-2 production via CD147-ERK-STAT3-MMP-2 pathway in hepatocellular carcinoma. Here, MMP2 is linked to hepatocellular carcinoma.